3-Hydroxyphenylboronic acid | CAS:87199-18-6

We serve 3-Hydroxyphenylboronic acid CAS:87199-18-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Hydroxyphenylboronic acid

Product Name: 3-Hydroxyphenylboronic acid
Other Name: 3-Hydroxyphenylboronic acid
CAS No: 87199-18-6
MF: C6H7BO3
MW: 137.92900
Density: 1.32 g/cm3
Boiling point: 370ºC at 760 mmHg
Melting point: 210-213 °C (dec.)(lit.)
Flash point: 177.6ºC
Refractive index: 1.582
UN Number: Non-dangerous goods
Transport hazard class: Non-dangerous goods
Packing group: Non-dangerous goods
 
Specification
Appearance: White powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 3-Hydroxyphenylboronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Hydroxyphenylboronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Hydroxyphenylboronic acid Use and application,3-Hydroxyphenylboronic acid technical grade,usp/ep/jp grade.


Related News: The national airlines of Egypt, Qatar and Saudi Arabia have halted flights to and from China.6-Methoxy-2-(4-methoxyphenyl)benzo[b]thiophene manufacturer From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats.6-(Trifluoromethyl)nicotinic acid supplier From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats.Phenylacetone vendor Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday.Factors that have a significant impact on the sales volume of APIs come from the production side, which mainly includes costs and processes.